Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer
Open Access
- 10 November 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1287505
Abstract
One of the primary diseases that cause death worldwide is cancer. Cancer cells can be intrinsically resistant or acquire resistance to therapies and drugs used for cancer treatment through multiple mechanisms of action that favor cell survival and proliferation, becoming one of the leading causes of treatment failure against cancer. A promising strategy to overcome chemoresistance and radioresistance is the co-administration of anticancer agents and natural compounds with anticancer properties, such as the polyphenolic compound resveratrol (RSV). RSV has been reported to be able to sensitize cancer cells to chemotherapeutic agents and radiotherapy, promoting cancer cell death. This review describes the reported molecular mechanisms by which RSV sensitizes tumor cells to radiotherapy and chemotherapy treatment.Keywords
This publication has 326 references indexed in Scilit:
- Role of Glutathione in Cancer Progression and ChemoresistanceOxidative Medicine and Cellular Longevity, 2013
- Crosstalk of reactive oxygen species and NF-κB signalingCell Research, 2010
- Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agentsLaboratory Investigation, 2010
- Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancerInternational Journal of Cancer, 2009
- Metabolic constituents of grapevine and grape-derived productsPhytochemistry Reviews, 2009
- Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem CellsCancer Cell, 2009
- Hypoxia-Inducible Factors, Stem Cells, and CancerCell, 2007
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- ROS stress in cancer cells and therapeutic implicationsDrug Resistance Updates, 2004
- IAP proteins: blocking the road to death's doorNature Reviews Molecular Cell Biology, 2002